Studies have indicated that MASLD can be screened using the Fibrosis Index Based on 4 Factors (FIB-4), which generates a single score by integrating patient age with measurements of three biomarkers: aspartate aminotransferase, alanine aminotransferase, and platelet count (25, 26). Here, GPT is linked to fibrosis.